Build status - In Progress

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis
Recruiting
40 years - 99 years
All
Phase N/A
1 Location

Brief description of study

This study is looking to see if inhaled treprostinil helps patients with IPF improve their pulmonary function tests. Patients will randomized to either placebo or inhaled treprostinil and will also undergo the following throughout the study: PFTs, physical exams, EKGs, HRCT, questionnaires, vital signs, lab tests

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Pulmonary Fibrosis
  • Age: 40 years - 99 years
  • Gender: All

Male or Female Over 40 Years of age Idiopathic Pulmonary Fibrosis

Updated on 04 Aug 2024. Study ID: 849703

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center